[p53 and HER-2/neu expression in relation to chemotherapy in non-small cell lung cancer patients].
Fijołek
Justyna
J
III Kliniki Chorób Płuc, Instytutu Gruźlicy i Chorób Płuc w Warszawie.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry* / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008175:Lung Neoplasms; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis*
D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53